Ildstad Suzanne has sold 2,905,142 shares of Talaris Therapeutics, Inc. [TALS] at $2.15 a share.
Talaris Therapeutics, Inc. [TALS] disclosed in an SEC Form 4 submission Monday, April 17, 2023 that the deal increased Ildstad Suzanne's holding in the company to 49,211.
Talaris Therapeutics, Inc. [TALS] is a Biological Products, Except Diagnostic Substances company based in Delaware.
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.